Efficacy of Levamlodipine Besylate and Felodipine in the Treatment of Patients with Essential Hypertension
10.3969/j.issn.1673-9701.2009.18.060
- VernacularTitle:苯磺酸左旋氨氯地平治疗原发性高血压疗效观察
- Author:
Weizhao CAO
1
;
Zhicun LI
Author Information
1. 广东省东莞市石龙人民医院
- Keywords:
Levamlodipine besylate;
Felodipine;
Essential hypertension;
Untoward reaction
- From:
China Modern Doctor
2009;47(18):117-118,125
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of ievamlodipine besylate and felodipine for patients with mild and moderate essential hypertension. Methods One hundred and four eases with essential hypertension were divided randomly into two groups:levamlodipine besylate group and felodipine group. Treatment lasted for 4 weeks. Parameters of blood pressure were measured before and after treatment. Results There was no significant difference in responder rates between patients taking levamlodipin besylate(84.62%) and patients taking felodipine(80.77%)(P>0.05). The untoward reaction in patients taking levamlodipine besylate(7.69%) was lower than that in patients taking felodipine(17.31%)(P < 0.05). Conclusion Levamlodipine besylate has effective at lowering blood pressure and light untoward reaction.
